Business
Zomedica Announces "Friday at Four" Webinar on November 21st Providing Strategic Overview & Third Quarter 2025 Business Review
Zomedica Announces "Friday at Four" Webinar on November 21st Providing Strategic Overview & Third Quarter 2025 Business Review.
About this update from Zomedica Corp.
[{"type":"text","content":"\r\n\r\n \r\n \r\n Zomedica Announces \"Friday at Four\" Webinar on November 21st Providing Strategic Overview & Third Quarter 2025 Business Review\r\n \r\n \r\n\r\n\r\nZomedica Announces \"Friday at Four\" Webinar on November 21st Providing Strategic Overview & Third Quarter 2025 Business Review\r\n\r\n\r\n\r\n\r\n\r\nNovember session to provide strategic context for Zomedica's product platforms featured in the previous Fourth Friday at Four Webinars ANN ARBOR, MI / ACCESS Newswire / November 11, 2025 / Zomedica Corp. (OTCQB:ZOMDF) (\"Zomedica\" or the \"Company\"), an animal health company offering innovative diagnostic and therapeutic devices for equine and companion animals, today announced a special session of its \"Fourth Friday at Four\" investor webinar series. To accommodate the holiday calendar, this month's webinar will be held on the third Friday-November 21, 2025 at 4:00 p.m. Eastern Time.\r\n The November program will provide a comprehensive overview of Zomedica's strategy-to-date, a review of third-quarter performance, and a look ahead at the Company's execution priorities to close out 2025 and enter 2026. Investors and interested stakeholders can register here: https://sholink.to/NovemberFriday.\r\n Webinar Details\r\n \r\n Title: \"Friday at Four\" Strategic Overview & Third Quarter Review\r\n Date/Time: Friday, November 21, 2025, at 4:00 p.m. Eastern Time\r\n Registration: https://sholink.to/NovemberFriday\r\n Format: Prepared remarks followed by Question & Answer session\r\n \r\n A replay will be available following the event for those unable to attend live.\r\n About Zomedica\r\n Zomedica is a leading equine and companion animal health company dedicated to improving animal health by providing veterinarians with innovative therapeutic and diagnostic solutions. Our gold standard PulseVet® shock wave system, which accelerates healing in musculoskeletal conditions, has transformed veterinary therapeutics. Our suite of products also includes the Assisi® line of therapeutic devices, the TRUFORMA® diagnostic platform, the TRUVIEW® digital cytology system, the VetGuardian® Zero Touch™ monitoring system, and Vetigel® hemostatic gel, a revolutionary hemostatic agent that rapidly stops bleeding, each designed to empower veterinarians to deliver top-tier care. In the a...